International Event

Slush 2025, one of the most important international events for startups, investors, and innovators. With over 10,000 participants in recent editions, Slush is the go-to event in the Nordic region for those looking to scale a startup globally.

The third annual meeting of Spoke 3 of the National Center for Gene Therapy and RNA-based Drugs focuses on advancing innovative therapies for central nervous system disorders.

Global Health Exhibition is the convergence of healthcare innovation, investment, and impact, bringing together global leaders across public and private sectors to drive conversations and action around the future of care.

The Commission’s flagship research and innovation event brings together policymakers, researchers, stakeholders and the public to debate and shape the future of research and innovation in Europe and beyond.

This EMBO workshop will bring together experts in the editing space, who are studying the CRISPR-Cas immune defence system, developing novel and safer editing approaches, and applying them to the clinic.

BioHackathon Europe is an annual event that brings together bioinformaticians and computational biologists from around the world. It’s organised by ELIXIR Europe, and offers an intense week of hacking, with participants working on diverse and exciting projects.

CIBB promotes dialogue between bioinformaticians, biostatisticians, computer scientists, and biologists, providing a multidisciplinary space to present innovative research.

Participants will learn fundamental concepts and advanced approaches to reconstruct the demographic history of populations and infer natural selection, using both classic and machine learning-based techniques.

Federated life science data analysis: Overcoming challenges for global impact.

The School will allow the participants to gain expertise on state-of-the-art concepts, methods and applications from both cancer biology, computational science and biomedical AI, and to get a glimpse into the vision of pioneers in the field of cancer evolution.